{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T18:30:33Z","timestamp":1758479433536},"reference-count":29,"publisher":"Wiley","issue":"s3","license":[{"start":{"date-parts":[[2011,3,28]],"date-time":"2011-03-28T00:00:00Z","timestamp":1301270400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Gastro and Hepatol"],"published-print":{"date-parts":[[2011,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background:\u2002<\/jats:bold> Functional gastrointestinal disorders are common worldwide.<\/jats:p><jats:p><jats:bold>Aim:\u2002<\/jats:bold> To review functional gastrointestinal disorder prevalence, diagnosis and treatment in New Zealand.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> A Medline search was performed to identify all published studies relating to prevalence, diagnosis and treatment of functional gastrointestinal disorders in New Zealand.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Reflux prevalence is 30% and non\u2010reflux dyspepsia is 34.2%. Helicobacter pylori prevalence varies considerably in NZ by geographical area and ethnicity and overall prevalence of infection is 24% in adults. 50% of patients with dyspepsia presenting for endoscopy in NZ will have no mucosal abnormality identified. National Dyspepsia Guidelines assist in management of patients. Guidelines exist for undifferentiated dyspepsia, Gastro\u2010oesophageal Reflux Disease (GORD), H. pylori, peptic ulcer, NSAID's and gastrointestinal complications. Irritable Bowel Syndrome (IBS) is reported by 21% of adults. Symptoms were more than twice as frequent and severe in females than males. Access to colonoscopy for investigation of bowel symptoms is limited in NZ and priority is given to patients with \u201calarm features\u201d. Non\u2010invasive markers of inflammation, such as faecal calprotectin, are being used to differentiate the patient with functional diarrhoea from inflammatory bowel disease. Treatment for irritable bowel symptoms is targeted to the predominant symptom.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> Functional gastrointestinal disorders are common in New Zealand. There is increasing awareness of dietary management for functional bowel symptoms.<\/jats:p>","DOI":"10.1111\/j.1440-1746.2011.06645.x","type":"journal-article","created":{"date-parts":[[2011,3,29]],"date-time":"2011-03-29T00:49:07Z","timestamp":1301359747000},"page":"15-18","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Functional gastrointestinal disorders in New Zealand"],"prefix":"10.1111","volume":"26","author":[{"given":"John W","family":"Wyeth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,3,28]]},"reference":[{"key":"e_1_2_6_2_2","unstructured":"Ministry of Social Development.The Social Report 2010; 10th Edition 2010. Cited 6 Nov 2010. Available from URL:http:\/\/www.socialreport.msd.govt.nz\/people\/index.html"},{"key":"e_1_2_6_3_2","volume-title":"Alcohol Use in New Zealand: Analysis of the 2004 New Zealand Health Behaviours Survey\u2014Alcohol Use","author":"Ministry of Health","year":"2007"},{"key":"e_1_2_6_4_2","volume-title":"Tobacco Trends 2006: Monitoring Tobacco Use in New Zealand","author":"Ministry of Health","year":"2006"},{"key":"e_1_2_6_5_2","volume-title":"A Portrait of Health: Key Results of the 2006\/07 New Zealand Health Survey","author":"Ministry of Health","year":"2008"},{"key":"e_1_2_6_6_2","first-page":"178","article-title":"Prevalence, severity and associated features of gastro\u2010oesophageal reflux and dyspepsia: a population\u2010based study","volume":"113","author":"Haque M","year":"2000","journal-title":"N. Z. Med. J."},{"key":"e_1_2_6_7_2","first-page":"333","article-title":"Abdominal Pain in New Zealand general practice","volume":"110","author":"Frear D","year":"1997","journal-title":"N. Z. Med. J."},{"key":"e_1_2_6_8_2","unstructured":"HuntRH XiaoSD MegraudFet\u2003al.Helicobacter pylori in developing countries\u2014practice guidelines. World Gastroenterology Organisation 2010."},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.1996.tb02934.x"},{"issue":"1176","key":"e_1_2_6_10_2","first-page":"U479","article-title":"Nurse led dyspepsia clinic using the urea breath test for Helicobacter pylori","volume":"116","author":"Fraser AG","year":"2003","journal-title":"N. Z. Med. J."},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.1998.tb00652.x"},{"key":"e_1_2_6_12_2","first-page":"292","article-title":"Seroprevalence of Helicobacter pylori in the adult population of Christchurch: risk factors and relationship to dyspeptic symptoms and iron studies","volume":"112","author":"Collett JA","year":"1999","journal-title":"N. Z. Med. J."},{"key":"e_1_2_6_13_2","first-page":"11","article-title":"Can the urea breath test for H. pylori replace endoscopy for the assessment of dyspepsia in primary care?","volume":"111","author":"Fraser AG","year":"1998","journal-title":"N. Z. Med. J."},{"key":"e_1_2_6_14_2","first-page":"95","article-title":"Diagnostic tests for Helicobacter pylori \u2013 can they help select patients for endoscopy?","volume":"109","author":"Fraser AG","year":"1996","journal-title":"N. Z. Med. J."},{"key":"e_1_2_6_15_2","unstructured":"Management of Dyspepsia and Heartburn.Evidence based best practice Guideline. New Zealand Guidelines Group. June2004."},{"key":"e_1_2_6_16_2","unstructured":"Pharmaceutical Management Agency.Annual review. Pharmac Wellington.2009."},{"key":"e_1_2_6_17_2","first-page":"418","article-title":"Functional gastrointestinal symptoms in a Wellington community sample","volume":"103","author":"Welch G","year":"1990","journal-title":"N. Z. Med. J."},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6138.653"},{"key":"e_1_2_6_19_2","first-page":"1164","article-title":"Prevalence and correlates of irritable bowel symptoms in a New Zealand birth cohort","volume":"115","author":"Barbezat G","year":"2002","journal-title":"N. Z. Med. J."},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03741.x"},{"key":"e_1_2_6_21_2","unstructured":"Issues Paper.State of the specialist workforce crisis in New Zealand's public hospitals. Association of Medical Specialists August2010."},{"key":"e_1_2_6_22_2","unstructured":"Ministry of Health.Version 1: Gastroenterology Referral Guidelines and Prioritisation Criteria. Cited 22 May 2001. Available from URL:http:\/\/www.electiveservices.govt.nz\/guidelines\/colonoscopy\u2010cpac.html."},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c3369"},{"key":"e_1_2_6_24_2","first-page":"1214","article-title":"Faecal calprotectin: the case for a novel non\u2010invasive way of assessing intestinal inflammation","volume":"118","author":"Gearry R","year":"2005","journal-title":"N. Z. Med. J."},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.00531.x"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2009.06149.x"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-6047.2002.00287.x"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v13.i35.4771"},{"key":"e_1_2_6_29_2","first-page":"231","article-title":"Zyactinase stimulates the probiotic gut microflora whilst inhibiting pathogenic microflora","volume":"3","author":"Weir IE","year":"2008","journal-title":"Int. J. Probiotics Prebiotics"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1625\/jcam.6.97"}],"container-title":["Journal of Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1746.2011.06645.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1746.2011.06645.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T18:02:48Z","timestamp":1694541768000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1746.2011.06645.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,28]]},"references-count":29,"journal-issue":{"issue":"s3","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["10.1111\/j.1440-1746.2011.06645.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1746.2011.06645.x","archive":["Portico"],"relation":{},"ISSN":["0815-9319","1440-1746"],"issn-type":[{"value":"0815-9319","type":"print"},{"value":"1440-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,28]]},"assertion":[{"value":"2011-03-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}